{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:02:25Z","timestamp":1789981345193,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007471","name":"Northern Borders University","doi-asserted-by":"publisher","award":["NBU-CRP-2026-2510"],"award-info":[{"award-number":["NBU-CRP-2026-2510"]}],"id":[{"id":"10.13039\/501100007471","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00210-026-05576-3","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:42:53Z","timestamp":1781239373000},"page":"18827-18847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vitexin-loaded phytosomes protect against high-fat diet-induced MASLD modulating PI3K\/AKT\/mTOR\/SREBP-1c, Nrf2\/HO-1, NF-\u03baB\/COX-2, and apoptotic pathways"],"prefix":"10.1007","volume":"399","author":[{"given":"Ahmed MS","family":"Hegazy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayat B.","family":"Al-Ghafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda A. Al","family":"Doghaither","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekramy M.","family":"Elmorsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen M.","family":"Ghaith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Najem","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed G.","family":"Alfayoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer M. E.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"5576_CR1","doi-asserted-by":"publisher","first-page":"6641128","DOI":"10.1155\/2021\/6641128","volume":"2021","author":"IL Abdulai","year":"2021","unstructured":"Abdulai IL, Kwofie SK, Gbewonyo WS, Boison D, Puplampu JB, Adinortey MB (2021) Multitargeted effects of vitexin and isovitexin on diabetes mellitus and its complications. Sci World J 2021:6641128","journal-title":"Sci World J"},{"key":"5576_CR2","doi-asserted-by":"crossref","unstructured":"Alfawaz M, Elmorsy EM, Alshammari AN, Hakim NA, Jawad NM, Hassan SA, Fawzy MS, Esmaeel SE (2025) Carvacrol-loaded chitosan nanoparticles as a multifunctional nanotherapeutic strategy targeting oxidative stress, inflammation, apoptosis, and genotoxicity in nonalcoholic fatty liver disease. Antioxidants (Basel) 14:1432-1432","DOI":"10.3390\/antiox14121432"},{"key":"5576_CR3","doi-asserted-by":"crossref","unstructured":"Arroyave-Ospina JC, Wu Z, Geng Y, Moshage H (2021) Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy. Antioxidants (Basel) 10:174\u2013174","DOI":"10.3390\/antiox10020174"},{"key":"5576_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jff.2017.03.038","volume":"33","author":"A Babazadeh","year":"2017","unstructured":"Babazadeh A, Ghanbarzadeh B, Hamishehkar H (2017) Phosphatidylcholine-rutin complex as a potential nanocarrier for food applications. J Funct Foods 33:134\u2013141","journal-title":"J Funct Foods"},{"key":"5576_CR5","doi-asserted-by":"crossref","unstructured":"Barani M, Sangiovanni E, Angarano M, Rajizadeh MA, Mehrabani M, Piazza S, Gangadharappa HV, Pardakhty A, Mehrbani M, Dell\u2019Agli M (2021) Phytosomes as innovative delivery systems for phytochemicals: a comprehensive review of literature. Int J Nanomed 16:6983\u20137022","DOI":"10.2147\/IJN.S318416"},{"key":"5576_CR6","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.18632\/oncotarget.22890","volume":"9","author":"M Bhardwaj","year":"2017","unstructured":"Bhardwaj M, Cho HJ, Paul S, Jakhar R, Khan I, Lee S-J, Kim B-Y, Krishnan M, Khaket TP, Lee HG (2017) Vitexin induces apoptosis by suppressing autophagy in multi-drug resistant colorectal cancer cells. Oncotarget 9:3278","journal-title":"Oncotarget"},{"key":"5576_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA, Network NCR (2011) Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 53:810\u2013820","journal-title":"Hepatology"},{"key":"5576_CR8","doi-asserted-by":"crossref","unstructured":"Chethan I, Vaijanathappa J (2025) Evaluation of the hepatoprotective properties of vitex altissima bark extracts and isolated bioactive: in-vitro and in-vivo approach. Eur J Med Chem Rep 16:100312","DOI":"10.1016\/j.ejmcr.2025.100312"},{"key":"5576_CR9","doi-asserted-by":"crossref","unstructured":"Cilen\u0161ek I, Ramu\u0161 SM, Petrovi\u010d MG, Petrovi\u010d D (2016) The glutathione reductase (GSR) polymorphisms (rs1002149 and rs8191009) and diabetic retinopathy in Slovenian subjects with type 2 diabetes mellitus. Enzyme 3:4","DOI":"10.15761\/BGG.1000120"},{"key":"5576_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3920\/WMJ2017.2267","volume":"11","author":"E Da Silva","year":"2018","unstructured":"Da Silva E, Bracarense A, Oswald IP (2018) Mycotoxins and oxidative stress: where are we? World Mycotoxin J 11:113\u2013134","journal-title":"World Mycotoxin J"},{"key":"5576_CR11","doi-asserted-by":"crossref","unstructured":"Direito R, Reis C, Roque L, Gon\u00e7alves M, Sanches-Silva A, Gaspar MM, Pinto R, Rocha J, Sepodes B, Ros\u00e1rio Bronze M (2019) Phytosomes with persimmon (Diospyros kaki L.) extract: preparation and preliminary demonstration of in vivo tolerability. Pharmaceutics 11:296","DOI":"10.3390\/pharmaceutics11060296"},{"key":"5576_CR12","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1158\/1078-0432.CCR-15-0364","volume":"21","author":"CJ Gibson","year":"2015","unstructured":"Gibson CJ, Davids MS (2015) BCL-2 antagonism to target the intrinsic mitochondrial pathway of apoptosis. Clin Cancer Res 21:5021\u20135029","journal-title":"Clin Cancer Res"},{"key":"5576_CR13","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3390\/jpm13040626","volume":"13","author":"S Haro Gir\u00f3n","year":"2023","unstructured":"Haro Gir\u00f3n S, Monserrat Sanz J, Ortega MA, Garcia-Montero C, Fraile-Mart\u00ednez O, G\u00f3mez-Lahoz AM, Boaru DL, de Leon-Oliva D, Guijarro LG, Atienza-Perez M (2023) Prognostic value of malondialdehyde (MDA) in the temporal progression of chronic spinal cord injury. J Personalized Med 13:626","journal-title":"J Personalized Med"},{"key":"5576_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27533","author":"H Hasnat","year":"2024","unstructured":"Hasnat H, Shompa SA, Islam MM, Alam S, Richi FT, Emon NU, Ashrafi S, Ahmed NU, Chowdhury MNR, Fatema N (2024) Flavonoids: a treasure house of prospective pharmacological potentials. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27533","journal-title":"Heliyon"},{"key":"5576_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajme.2017.09.001","volume":"54","author":"O Ighodaro","year":"2018","unstructured":"Ighodaro O, Akinloye O (2018) First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alexandria J Med 54:287\u2013293","journal-title":"Alexandria J Med"},{"key":"5576_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbrc.2019.08.139","volume":"519","author":"S Inamdar","year":"2019","unstructured":"Inamdar S, Joshi A, Malik S, Boppana R, Ghaskadbi S (2019) Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice. Biochem Biophys Res Commun 519:106\u2013112","journal-title":"Biochem Biophys Res Commun"},{"key":"5576_CR17","doi-asserted-by":"crossref","unstructured":"Isoje EF, Okoro IO, Apiamu A, Okpoghono J (2025) Changes in liver function markers and lipid profile of rats administered rainy and dry season Amaranthus spinosus methanol extract and lead acetate. Food Chem Adv 8:101049","DOI":"10.1016\/j.focha.2025.101049"},{"key":"5576_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tem.2011.10.004","volume":"23","author":"T-I Jeon","year":"2012","unstructured":"Jeon T-I, Osborne TF (2012) SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab 23:65\u201372","journal-title":"Trends Endocrinol Metab"},{"key":"5576_CR19","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.intimp.2011.01.036","volume":"11","author":"G Ji","year":"2011","unstructured":"Ji G, Yang Q, Hao J, Guo L, Chen X, Hu J, Leng L, Jiang Z (2011) Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms. Int Immunopharmacol 11:762\u2013768","journal-title":"Int Immunopharmacol"},{"key":"5576_CR20","doi-asserted-by":"publisher","first-page":"1743899","DOI":"10.3389\/fnut.2025.1743899","volume":"12","author":"S Jiang","year":"2025","unstructured":"Jiang S, Zhai L, Shao Y, Sun F, Liu X (2025) Targeting the PI3K\/AKT signaling pathway: an important molecular mechanism of herbal medicine in the treatment of MASLD\/MASH. Front Nutr 12:1743899","journal-title":"Front Nutr"},{"key":"5576_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1248\/bpb.b21-00716","volume":"45","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Gong Q, Gong Y, Zhuo C, Huang J, Tang Q (2022) Vitexin attenuates non-alcoholic fatty liver disease lipid accumulation in high fat-diet fed mice by activating autophagy and reducing endoplasmic reticulum stress in liver. Biol Pharm Bull 45:260\u2013267","journal-title":"Biol Pharm Bull"},{"key":"5576_CR22","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1016\/j.apsb.2022.01.002","volume":"12","author":"Z Ju","year":"2022","unstructured":"Ju Z, Li M, Xu J, Howell DC, Li Z, Chen F-E (2022) Recent development on COX-2 inhibitors as promising anti-inflammatory agents: the past 10 years. Acta Pharm Sin B 12:2790\u20132807","journal-title":"Acta Pharm Sin B"},{"key":"5576_CR23","doi-asserted-by":"crossref","unstructured":"Kan C, Zhang K, Wang Y, Zhang X, Liu C, Ma Y, Hou N, Huang N, Han F, Sun X (2025) Global burden and future trends of metabolic dysfunction-associated steatotic liver disease: 1990\u20132021 to 2045. Ann Hepatol 30:101898\u2013101898","DOI":"10.1016\/j.aohep.2025.101898"},{"key":"5576_CR24","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1177\/0960327119851255","volume":"38","author":"S Karimi Ardestani","year":"2019","unstructured":"Karimi Ardestani S, Tafvizi F, Tajabadi Ebrahimi M (2019) Heat-killed probiotic bacteria induce apoptosis of HT-29 human colon adenocarcinoma cell line via the regulation of Bax\/Bcl2 and caspases pathway. Hum Exp Toxicol 38:1069\u20131081","journal-title":"Hum Exp Toxicol"},{"key":"5576_CR25","doi-asserted-by":"crossref","unstructured":"Khairnar R, Islam MA, Fleishman J, Kumar S (2023) Shedding light on non-alcoholic fatty liver disease: pathogenesis, molecular mechanisms, models, and emerging therapeutics. Life Sci 312:121185\u2013121185","DOI":"10.1016\/j.lfs.2022.121185"},{"key":"5576_CR26","doi-asserted-by":"publisher","first-page":"13250","DOI":"10.1074\/jbc.RA120.014907","volume":"295","author":"JR Krycer","year":"2020","unstructured":"Krycer JR, Quek L-E, Francis D, Zadoorian A, Weiss FC, Cooke KC, Nelson ME, Diaz-Vegas A, Humphrey SJ, Scalzo R (2020) Insulin signaling requires glucose to promote lipid anabolism in adipocytes. J Biol Chem 295:13250\u201313266","journal-title":"J Biol Chem"},{"key":"5576_CR27","doi-asserted-by":"crossref","unstructured":"Li N, Li X, Ding Y, Liu X, Diggle K, Kisseleva T, Brenner DA (2023) SREBP regulation of lipid metabolism in liver disease, and therapeutic strategies. Biomedicines 11:3280-3280","DOI":"10.3390\/biomedicines11123280"},{"key":"5576_CR28","doi-asserted-by":"crossref","unstructured":"Liu B, Yao Z, Song L, Sun C, Shen C, Cheng F, Cheng Z, Zhang R, Liu R (2025) Vitexin alleviates lipid metabolism disorders and hepatic injury in obese mice through the PI3K\/AKT\/mTOR\/SREBP-1c pathway. Eur J Med Chem 287:117379-117379","DOI":"10.1016\/j.ejmech.2025.117379"},{"key":"5576_CR29","first-page":"1","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2:1\u20139","journal-title":"Signal Transduct Target Ther"},{"key":"5576_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method. Methods (San Diego Calif) 25:402\u2013408","journal-title":"Methods (San Diego Calif)"},{"key":"5576_CR31","first-page":"265","volume":"14","author":"M Lu","year":"2019","unstructured":"Lu M, Qiu Q, Luo X, Liu X, Sun J, Wang C, Lin X, Deng Y, Song Y (2019) Phyto-phospholipid complexes (phytosomes): a novel strategy to improve the bioavailability of active constituents. Asian J Pharm Sci 14:265\u2013274","journal-title":"Asian J Pharm Sci"},{"key":"5576_CR32","doi-asserted-by":"crossref","unstructured":"Mahboob A, Samuel SM, Mohamed A, Wani MY, Ghorbel S, Miled N, B\u00fcsselberg D, Chaari A (2023) Role of flavonoids in controlling obesity: molecular targets and mechanisms. Front Nutr 10:1177897\u20131177897","DOI":"10.3389\/fnut.2023.1177897"},{"key":"5576_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/1567202617666191223144715","volume":"17","author":"S Mao","year":"2020","unstructured":"Mao S, Luo X, Li Y, He C, Huang F, Su C (2020) Role of PI3K\/AKT\/mTOR pathway associated oxidative stress and cardiac dysfunction in takotsubo syndrome. Curr Neurovasc Res 17:35\u201343","journal-title":"Curr Neurovasc Res"},{"key":"5576_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112934","volume":"150","author":"KK Noor","year":"2022","unstructured":"Noor KK, Ijaz MU, Ehsan N, Tahir A, Yeni DK, Zihad SNK, Uddin SJ, Ashraf A, Simal-Gandara J (2022) Hepatoprotective role of vitexin against cadmium-induced liver damage in male rats: A biochemical, inflammatory, apoptotic and histopathological investigation. Biomed Pharmacother 150:112934","journal-title":"Biomed Pharmacother"},{"key":"5576_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.nfs.2023.03.001","volume":"31","author":"M Peanparkdee","year":"2023","unstructured":"Peanparkdee M, Yooying R (2023) Enhancement of solubility, thermal stability and bioaccessibility of vitexin using phosphatidylcholine-based phytosome. NFS J 31:28\u201338","journal-title":"NFS J"},{"key":"5576_CR36","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1080\/10408398.2020.1753165","volume":"61","author":"Y Peng","year":"2021","unstructured":"Peng Y, Gan R, Li H, Yang M, McClements DJ, Gao R, Sun Q (2021) Absorption, metabolism, and bioactivity of vitexin: recent advances in understanding the efficacy of an important nutraceutical. Crit Rev Food Sci Nutr 61:1049\u20131064","journal-title":"Crit Rev Food Sci Nutr"},{"key":"5576_CR37","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.3390\/ijms25115640","volume":"25","author":"P Portincasa","year":"2024","unstructured":"Portincasa P, Khalil M, Mahdi L, Perniola V, Idone V, Graziani A, Baffy G, Di Ciaula A (2024) Metabolic dysfunction\u2013associated steatotic liver disease: from pathogenesis to current therapeutic options. Int J Mol Sci 25:5640","journal-title":"Int J Mol Sci"},{"key":"5576_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.31254\/phyto.2023.12107","volume":"12","author":"R Ranjan","year":"2023","unstructured":"Ranjan R, Kishore K, Ranjan R, Sheikh T, Kumar A, Kumar B, Kumar S, Kumar R (2023) Nutraceutical potential of vitexin: a flavone glycoside. J Phytopharm 12:44\u201350","journal-title":"J Phytopharm"},{"key":"5576_CR39","doi-asserted-by":"publisher","first-page":"1161521","DOI":"10.3389\/fendo.2023.1161521","volume":"14","author":"R Ruze","year":"2023","unstructured":"Ruze R, Liu T, Zou X, Song J, Chen Y, Xu R, Yin X, Xu Q (2023) Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments. Front Endocrinol 14:1161521","journal-title":"Front Endocrinol"},{"key":"5576_CR40","doi-asserted-by":"crossref","unstructured":"Savova MS, Mihaylova LV, Tews D, Wabitsch M, Georgiev MI (2023) Targeting PI3K\/AKT signaling pathway in obesity. Biomed Pharmacother 159:114244\u2013114244","DOI":"10.1016\/j.biopha.2023.114244"},{"key":"5576_CR41","doi-asserted-by":"crossref","unstructured":"Sharma P, Kaushal N, Saleth LR, Ghavami S, Dhingra S, Kaur P (2023) Oxidative stress-induced apoptosis and autophagy: Balancing the contrary forces in spermatogenesis. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1869:166742","DOI":"10.1016\/j.bbadis.2023.166742"},{"key":"5576_CR42","doi-asserted-by":"crossref","unstructured":"Sun J, Liu J, Chen F, Wang X, Wu G (2025) Exploring the significance of fatty acid metabolism reprogramming in the pathogenesis of cancer and anticancer therapy. Ann Med 57:2445774\u2013 2445774","DOI":"10.1080\/07853890.2024.2445774"},{"key":"5576_CR43","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/07853890.2019.1693056","volume":"51","author":"L Sun","year":"2019","unstructured":"Sun L, Yin H, Liu M, Xu G, Zhou X, Ge P, Yang H, Mao Y (2019) Impaired albumin function: a novel potential indicator for liver function damage? Ann Med 51:333\u2013344","journal-title":"Ann Med"},{"key":"5576_CR44","doi-asserted-by":"crossref","unstructured":"Talebi M, Shahbazi K, Dakkali MS, Akbari M, Ghale RA, Hashemi S, Sashourpour M, Mojab F, Aminzadeh S (2025) Phytosomes: a promising nanocarrier system for enhanced bioavailability and therapeutic efficacy of herbal products. Phytomed Plus 5:100779","DOI":"10.1016\/j.phyplu.2025.100779"},{"key":"5576_CR45","doi-asserted-by":"crossref","unstructured":"Tang S-p, Mao X-l, Chen Y-h, Yan L-l, Ye L-p, Li S-w (2022) Reactive oxygen species induce fatty liver and ischemia-reperfusion injury by promoting inflammation and cell death. Front Immunol 13:870239\u2013870239","DOI":"10.3389\/fimmu.2022.870239"},{"key":"5576_CR46","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","volume":"81","author":"V Taru","year":"2024","unstructured":"Taru V, Szabo G, Mehal W, Reiberger T (2024) Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation. J Hepatol 81:895\u2013910","journal-title":"J Hepatol"},{"key":"5576_CR47","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","volume":"29","author":"ML Teng","year":"2022","unstructured":"Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, Yang JD, Tan E, Muthiah MD (2022) Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol 29:S32","journal-title":"Clin Mol Hepatol"},{"key":"5576_CR48","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1079\/BJN2001340","volume":"86","author":"R Van den Berg","year":"2001","unstructured":"Van den Berg R, Haenen G, Van den Berg H, Bast A (2001) Transcription factor NF-\u03baB as a potential biomarker for oxidative stress. Br J Nutr 86:S121\u2013S127","journal-title":"Br J Nutr"},{"key":"5576_CR49","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.3390\/ijms18122772","volume":"18","author":"S Vomund","year":"2017","unstructured":"Vomund S, Sch\u00e4fer A, Parnham MJ, Br\u00fcne B, Von Knethen A (2017) Nrf2, the master regulator of anti-oxidative responses. Int J Mol Sci 18:2772","journal-title":"Int J Mol Sci"},{"key":"5576_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s43066-025-00452-w","volume":"15","author":"P Wal","year":"2025","unstructured":"Wal P, Yadav S, Jha SK, Singh A, Bhargavi B, Shivaram R, Imran M, Aziz N (2025) Role of natural compounds in non-alcoholic fatty liver diseases (NAFLD): a mechanistic approach. Egypt Liver J 15:50\u201350","journal-title":"Egypt Liver J"},{"key":"5576_CR51","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41420-024-02168-z","volume":"10","author":"H-l Xu","year":"2024","unstructured":"Xu H-l, Wan S-r, An Y, Wu Q, Xing Y-h, Deng C-h, Zhang P-p, Long Y, Xu B-t, Jiang Z-z (2024) Targeting cell death in NAFLD: mechanisms and targeted therapies. Cell Death Discov 10:399","journal-title":"Cell Death Discov"},{"key":"5576_CR52","doi-asserted-by":"publisher","first-page":"100149","DOI":"10.1016\/j.metop.2021.100149","volume":"12","author":"P Zarghamravanbakhsh","year":"2021","unstructured":"Zarghamravanbakhsh P, Frenkel M, Poretsky L (2021) Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD). Metab Open 12:100149\u2013100149","journal-title":"Metab Open"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05576-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05576-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05576-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:11:37Z","timestamp":1789978297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05576-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5576"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05576-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study protocol was approved by the Institutional Animal Care and Use Committee of Mansoura University (MU-ACUC, VM.R.26.01.101). All procedures were carried out in accordance with Directive 2010\/63\/EU and the ARRIVE guidelines 2.0.","order":1,"name":"Ethics","label":"Animal ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that no artificial intelligence (AI) or AI-assisted technologies were used in this study.","order":5,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}